Grandt Daniel, Gamstätter Thomas, Fölsch Ulrich R
Kommission Arzneimitteltherapie-Management und Arzneimitteltherapiesicherheit, Deutsche Gesellschaft für Innere Medizin e. V. (DGIM).
Dtsch Med Wochenschr. 2020 Oct;145(20):1504-1508. doi: 10.1055/a-1234-9684. Epub 2020 Oct 6.
Applying guidelines in patients with multimorbidity can result in dangerous or contraindicated drug-drug and drug-disease-interactions. A representative working group of medical scientific associations identifies such therapeutic conflicts and develops management strategies that will be published as a formally consensus based (S2K) guideline. Rational, aims and methods used are described, as well as evaluation and updating of recommendations.
在患有多种疾病的患者中应用指南可能会导致危险的或禁忌的药物相互作用及药物与疾病的相互作用。一个由医学科学协会组成的代表性工作组识别出此类治疗冲突，并制定管理策略，这些策略将作为基于正式共识（S2K）的指南予以发布。文中描述了所采用的合理依据、目标和方法，以及建议的评估和更新。
